1. Yacoubian TA, Standaret DG. Targets for neuroprotection in Parkinson’s disease. Biochemica et Biophysica Acta 2009:1792(7):676-687.
2. Munch G, Gerlach M, Sian J, Wong A, Riederer P. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Annals of Neurology 1998;44:S85-8.
3. Serra JA, Dominguez RO, de Lustig ES, Guareschi EM, Famulari AL, Bartolome EL, et al. Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's Alzheimer's and vascular dementia patients. Journal of Neural Transmission 2001;108:1135-48.
4. Yan MH,Wang X,Zhu X. Mitochondria defectsand oxidative stress in Alzheimer disease and Parkinson disease. Free Radical Biology and Medicine 2013: 62; 90-101.
5. Mehraein F, Sarbishegi M, Aslani, A. Evaluation of effect of oleuropein on skin wound healing in aged male Balb/c mice. Cell Journal 2014: 16(1): 25-30.
6. Ravindran P BK. Shylaja M,ed Cinnamon and Cassia: The genus Cinnamomum. Danvers, Ma: CRC;2005.
7. Patra K, Bose S, Sarkar S, Rakshit J, Jana S, Mukherjee A, et al. Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinnamic acid. Chemico-biological Interactions 2012:195(3):231-239.
8. LI Y-q, Kong D-x, Wa H. Analysis and evaluation of essential oil components of cinnamon barks using GC-MS and FTIR spectroscopy. Industrial Crops and Products 2013:41;269-278.
9. Chauhan V, Chauhan A. Oxidative stress in Alzheimer’s disease. Pathophysiology 2006;13(3):195-208.
10. Jana A, Modi KK, Roy A, Anderson JA, van Breemen RB, Pahan K. Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. The Journal of Neuroimmune Pharmacology 2013; 8:739-755.
11. Azwanida NN. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Medicinal and Aromatic Plants 2015;4(3);1-6.
12. Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, et al. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Neuroscience Research 2005; 51(3): 299-308.
13. Pyo JH, Jeong YK, Yeo S, Lee JH, Jeong MY, Kim SH, et al. Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury. Biological and Pharmaceutical Bulletin 2013;36(12):1928-35.
14. Chen YF, Wang YW, Huang WS, Lee MM, Wood WG, Leung YM, et al. Trans- cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFκ-B signaling pathway. Neuromolecular Medicine 2016;18(3):322-33.
15. Klein RL, Lewis MH, Muzyczka N, Meyer EM. Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Research 1999; 847(2):314-20.
16. Jana A, Modi KK, Roy A, Anderson JA, van Breemen RB, and Pahan K. Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: Therapeutic implications for neurodegenerative disorders. Journal of Neuroimmune Pharmacology 2013;8(3):739-55.
17. Khasnavis S, Pahan K. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neuroimmune Pharmacology 2014;9(4):569-81.
18. Davies KJ, Shringarpure R. Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases. Neurology 2006;66:S93-6.
19. Gowder SJT, Halagowder D. Cinnamaldehyde induces behavioral and biochemical changes in the male albino Wistar rat. Journal of Medical Sciences 2010;3:101-109.
20. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, et al. Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2007:104:18754-18759.
21. Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. Journal of Immunology 2009; 183: 5917-5927.